Referrals
search
eNewsletter HealthPoints Sign up for our HealthPoints E-Newsletter
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
About Us
Alumni/ JJSS
Directory
Faculty, Alpha
Staff, Alpha
Leadership
Cardiothoracic Surgery
Center for Liver Disease and Transplantation (CLDT)
General Surgery
Division of Surgical Outcomes Research (InCHOIR)
Pediatric Surgery
Plastic Surgery
Surgical Science
Vascular Surgery
Research & Information Systems
Finance Office
External Affairs
Operations & Quality Management
Office of External Affairs
Progress Reports
Ways to Give

Bret Taback, MD

Positions and Appointments

2005-present  Assistant Professor of Surgery
Columbia University College of Physicians and Surgeons, New York, NY
2009-present  Director, Melanoma and Sarcoma
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
2010-Present  Director, Breast Surgery Fellowship
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
2005-present  Attending Surgeon
NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY

Clinical Specialties

Surgical Oncology
Breast Cancer

Research Interests

Tumor genetics and profiling
Micrometastasis and minimal residual disease surveillance
Circulating nucleic acids in plasma and serum


Education and Training

1999-2002  Fellow in the Department of Surgical Oncology
John Wayne Cancer Institute, Santa Monica, CA
1998-1999  Chief Resident in the Department of Surgery
Rhode Island Hospital/Brown University, Providence, RI
1996-1998  Resident in the Department of Surgery
Rhode Island Hospital/Brown University, Providence, RI
1994-1996  Research Fellow in the Department of Surgery, Division of Surgical Oncology
Beth Israel Deaconess Medical Center/Havard Medical School, Boston, MA
1991-1994  Resident in the Department of Surgery
Northwestern University Medical Center, Chicago, IL
1987-1991  MD
Tufts University School of Medicine, Boston, MA
1983-1987  BA, Biology
Brandeis University, Waltham, MA

Professional Experience

2002-2005  Associate Director, Department of Molecular Oncology
John Wayne Cancer Institute, Santa Monica, CA
2002-2005  Assistant Director, Joyce Eisenberg-Keefer Breast Center
John Wayne Cancer Institute, Santa Monica, CA
1999-2005  Staff, Surgical Oncology
Saint John's Health Center, Santa Monica, CA

Professional Honors

BMC Cancer Journal, Associate Editor, London, England (2010-Present)

American College of Surgeons Oncology Group (ACOSOG), Audit Committee Member (2009-Present)

Appointed the American College of Surgeons' Cancer Liaison
Physician for the Hospital Cancer Program at NewYork-Presbyterian Hospital, New York, NY (2006-Present)

Member, International Scientific Committee, The 4th International Sentinel Node Congress, Los Angeles, CA (2004)

Co-Chairman, The 3rd International Conference on Circulating Nucleic Acids in Plasma and Serum & Serum Proteomics (CNAPS III), Santa Monica, CA (2003)

Young Investigator Award, The 3rd International Sentinel Node Congress, Yokohama, Japan (2002)

Merit Award, American Society of Clinical Oncology,
Orlando, FL (2002)

Elected to Associate Member Council, American Association for Cancer Research, Philadelphia, PA (2001-2004)

Scholarship Award to attend Epidemiology and Biostatistics Conference, Berlex Oncology Foundation, Hackensack, NJ (2001)

Joyce Eisenberg-Keefer Fellowship Award, Santa Monica, CA (2000)

Merit Award, American Society of Clinical Oncology,
New Orleans, LA (2000)

Professional Societies and Committees

American Board of Surgery
Diplomate of the National Board of Medical Examiners
American Society of General Surgeons
American Association for Cancer Research
American Association for the Advancement of Science
American College of Surgeons
American Medical Association
American Society for Investigative Pathology
American Society of Clinical Oncology
Association for Academic Surgery
Society for Surgical Oncology
Society of Laparoendoscopic Surgery


Selected Publications

Huston TL, Taback B, Rohde CH. Chest wall reconstruction with porcine acellular dermal matrix (strattice) and a latissimus myocutaneous flap. Am Surg. 77:115-116, 2011

Whiffen A, El-Tamer M, Taback B, Feldman S, Joseph KA. Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia. Ann Surg Oncolol. 18:463-467, 2011

Sabatino M, Kim-Schulze S, Panelli MC, Stroncek D, Wang E, Taback B, Kim DW, Deraffele G, Pos Z, Marincola FM, Kaufman HL. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin Oncol. 27:2645-2652, 2009

Kaufman HL, Taback B, Sherman W, Kim DW, Shingler WH, Moroziewicz D, DeRaffele G, Mitcham J, Carroll MW, Harrop R, Naylor S, Kim-Schulze S. Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. J Transl Med. 7:2-13, 2009

Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle localization biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 16:1108-11, 2009

Kim-Schulze S, Kim HS, Wainstein A, Kim DW, Yang WC, Moroziewicz D, Mong PY, Bereta M, Taback B, Wang Q, Kaufman HL. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer. J Immunol. 181:8112-9, 2008

Kim-Schulze S, Taback B, Kaufman HL. Cytokine therapy for cancer. Surg Oncol Clin N Am. 16:793-818, 2007

Taback B, Giuliano A, Lai R, Hansen N, Singer F, Pantel K, Hoon D. Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. Ann N Y Acad Sci. 1075:211-221, 2006

Taback B, Saha S, Hoon D. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients. Ann N Y Acad Sci. 1075:197-203, 2006

Taback B, Nguyen P, Hansen N, Edwards G, Conway K, Giuliano A. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 13:1099-104, 2006

(Visit PubMed to view this faculty member's most recent articles.)

Selected Abstracts


Mackey A, Feldman S, El-Tamer M, Sandoval R, Hibshoosh H, Taback, B. Is surgeonís perception of margins during segmentectomy for breast cancer accurate ? Ann Surg Oncology 19. 2012 (suppl; abstr 212)

Le-Petross H, McCall L, Hunt K, Mittendorf, E, Ahrendt G, Wilke L, Leitch M, Taback B, Boughey J. Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071) J Clin Oncol 30. 2012 (suppl; abstr 1107)

Kalinsky K, Sparano JA, Kim M, Crew KD, Maurer MA, Taback B, Feldman SA, Hibshoosh H, Wiechmann L, Adelson KB, Hershman DL. Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable breast cancer. J Clin Oncol 29: 2011 (suppl; abstr TPS147)

Casher J, Keating S, Espinel CF, Hibshoosh H, Taback B, Joseph KP, El-Tamer M, Feldman SM. Mammaprint experience in an academic medical center. American Society of Clinical Oncology 2010; abstr 198

Mitchell S, Ascherman J, Rohde C, Taback B. A comprehensive assessment of tumescent injection and sharp dissection for skin-sparing mastectomy. American Society of Breast Surgeons Proceedings 2010; abstr 119

Whiffen A, Joseph K, El-Tamer M, Taback B, Feldman S, Greenberg E, Wang S. Predictors of breast cancer development in women diagnosed with atypical ductal hyperplasia and atypical lobular hyperplasia. American Society of Breast Surgeons Proceedings 2010; abstr 72

Espinel C, Keating S, Joseph K, Taback B, El-Tamer M, Feldman S. MammaPrint feasibility in a large academic medical center: initial experience. American Society of Breast Surgeons Proceedings 2010; abstr 161

Mangiameli D, Taback B, DeRaffele G, Kaufman H. An aggressive treatment regimen that includes high-dose Interleukin-2 immunotherapy is associated with a prolonged survival in select patients with ocular melanoma metastasis. Ann Surg Oncol 16:2009 (Feb Suppl 1; abstr P250)

Pocock B, Taback B, Klein L, Joseph K, El-Tamer M. Pre-operative needle biopsy and surgical evaluation of the axilla as quality measures in breast cancer surgery. Ann Surg Oncol 15:2009 (Feb Suppl 2; abstr P132)

Taback B, Honeyman C, Liu G, DeRaffele G, Kaufman H. Complete surgical resection of residual melanoma metastasis and survival in stage IV patients following high-dose IL-2 therapy. J Clin Oncol 26: 2008 (May 20 suppl; abstr 20000)

Taback B, Hansen N, Conway K, Giuliano A. Method of detection of local recurrence in patients following breast conserving surgery and its utility for surveillance. Proceedings of the American Society of Clinical Oncology 24: 611a, 2006

Liu Yong-Yu, Taback B, Yu J, Xie P, Gouaze V, Giuliano A, Cabot M. Glucosylceramide synthase, a modulator of drug resistance is overexpressed in metastatic breast cancer. Proceedings of the American Association for Cancer Research 47: 1260, 2006

Taback B, Saha S, Hoon D. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients. Clinical Chemistry 51: 11, 2005

(Visit PubMed to view this faculty member's most recent articles.)






Address:
Columbia University Medical Center
Herbert Irving Pavilion Room 1002
161 Fort Washington Avenue
New York, NY   10032

Phone: 212.305.9676
Fax: 212.305.1522






     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
Columbia University Medical Center NewYork-Presbyterian Hospital